CD28 and Grb-2, relative to Gads or Grap, preferentially co-operate with Vav1 in the activation of NFAT/AP-1 transcription

Biochemical and Biophysical Research Communications

Volumn 369, Issue 2, 2008, Pages 616-621

  Schneider, Helga ^a   Rudd, Christopher E ^a  

^a Immunology Division   (United Kingdom)

Author keywords

CD28; Grb 2; NFAT AP 1; Vav1

Indexed keywords

ADAPTOR PROTEIN; CD28 ANTIGEN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; INTERLEUKIN 2 INDUCIBLE T CELL KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN GADS; PROTEIN GRAP; PROTEIN KINASE; PROTEIN VAV1; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG; VAV PROTEIN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIGENS, CD28; GRB2 ADAPTOR PROTEIN; HUMANS; JURKAT CELLS; NFATC TRANSCRIPTION FACTORS; PROTO-ONCOGENE PROTEINS C-VAV; TRANS-ACTIVATION (GENETICS);

EID: 40849120481     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.02.068     Document Type: Article

References (39)

1. June C.H., Bluestone J.A., Nadler L.M., and Thompson C.B. The B7 and CD28 receptor families. Immunol. Today 15 (1994) 321-331
2. Riley J.L., and June C.H. The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation. Blood 105 (2005) 13-21
3. Greenwald R.J., Freeman G.J., and Sharpe A.H. The B7 family revisited. Annu. Rev. Immunol. 23 (2005) 515-548
4. Rudd C.E., and Schneider H. Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling. Nat. Rev. Immunol. 3 (2003) 544-556
5. Krummel M.F., and Allison J.P. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183 (1996) 2533-2540
6. Walunas T.L., Lenschow D.J., Bakker C.Y., Linsley P.S., Freeman G.J., Green J.M., Thompson C.B., and Bluestone J.A. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1 (1994) 405-413
7. Linsley P.S., and Golstein P. Lymphocyte activation: T-cell regulation by CTLA-4. Curr. Biol. 6 (1996) 398-400
8. Linsley P.S. New look at an old costimulator. Nat. Immunol. 6 (2005) 231-232
9. Prasad K.V., Cai Y.C., Raab M., Duckworth B., Cantley L., Shoelson S.E., and Rudd C.E. T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif. Proc. Natl. Acad. Sci. USA 91 (1994) 2834-2838
10. Truitt K.E., Hicks C.M., and Imboden J.B. Stimulation of CD28 triggers an association between CD28 and phosphatidylinositol 3-kinase in Jurkat T cells. J. Exp. Med. 179 (1994) 1071-1076
11. August A., and Dupont B. CD28 of T lymphocytes associates with phosphatidylinositol 3-kinase. Int. Immunol. 6 (1994) 769-774
12. Klasen S., Pages F., Peyron J.F., Cantrell D.A., and Olive D. Two distinct regions of the CD28 intracytoplasmic domain are involved in the tyrosine phosphorylation of Vav and GTPase activating protein-associated p62 protein. Int. Immunol. 10 (1998) 481-489
13. Pages F., Ragueneau M., Rottapel R., Truneh A., Nunes J., Imbert J., and Olive D. Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling. Nature 369 (1994) 327-329
14. Harada Y., Tanabe E., Watanabe R., Weiss B.D., Matsumoto A., Ariga H., Koiwai O., Fukui Y., Kubo M., June C.H., and Abe R. Novel role of phosphatidylinositol 3-kinase in CD28-mediated costimulation. J. Biol. Chem. 276 (2001) 9003-9008
15. Schneider H., Cai Y.C., Prasad K.V., Shoelson S.E., and Rudd C.E. T cell antigen CD28 binds to the Grb-2/SOS complex, regulators of p21ras. Eur. J. Immunol. 25 (1995) 1044-1050
16. Kim H.H., Tharayil M., and Rudd C.E. Growth factor receptor-bound protein 2 SH2/SH3 domain binding to CD28 and its role in co-signaling. J. Biol. Chem. 273 (1998) 296-301
17. Okkenhaug K., and Rottapel R. Grb2 forms an inducible protein complex with CD28 through a Src homology 3 domain-proline interaction. J. Biol. Chem. 273 (1998) 21194-21202
18. Watanabe R., Harada Y., Takeda K., Takahashi J., Ohnuki K., Ogawa S., Ohgai D., Kaibara N., Koiwai O., Tanabe K., Toma H., Sugamura K., and Abe R. Grb2 and Gads exhibit different interactions with CD28 and play distinct roles in CD28-mediated costimulation. J. Immunol. 177 (2006) 1085-1091
19. Carey K.D., Dillon T.J., Schmitt J.M., Baird A.M., Holdorf A.D., Straus D.B., Shaw A.S., and Stork P.J. CD28 and the tyrosine kinase lck stimulate mitogen-activated protein kinase activity in T cells via inhibition of the small G protein Rap1. Mol. Cell. Biol. 20 (2000) 8409-8419
20. Holdorf A.D., Green J.M., Levin S.D., Denny M.F., Straus D.B., Link V., Changelian P.S., Allen P.M., and Shaw A.S. Proline residues in CD28 and the Src homology (SH)3 domain of Lck are required for T cell costimulation. J. Exp. Med. 190 (1999) 375-384
21. Harada Y., Ohgai D., Watanabe R., Okano K., Koiwai O., Tanabe K., Toma H., Altman A., and Abe R. A single amino acid alteration in cytoplasmic domain determines IL-2 promoter activation by ligation of CD28 but not inducible costimulator (ICOS). J. Exp. Med. 197 (2003) 257-262
22. Bustelo X.R. Regulatory and signaling properties of the Vav family. Mol. Cell. Biol. 20 (2000) 1461-1477
23. Kuhne M.R., Ku G., and Weiss A. A guanine nucleotide exchange factor-independent function of Vav1 in transcriptional activation. J. Biol. Chem. 275 (2000) 2185-2190
24. Holsinger L.J., Graef I.A., Swat W., Chi T., Bautista D.M., Davidson L., Lewis R.S., Alt F.W., and Crabtree G.R. Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction. Curr. Biol. 8 (1998) 563-572
25. Fischer K.D., Kong Y.Y., Nishina H., Tedford K., Marengere L.E., Kozieradzki I., Sasaki T., Starr M., Chan G., Gardener S., Nghiem M.P., Bouchard D., Barbacid M., Bernstein A., and Penninger J.M. Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor. Curr. Biol. 8 (1998) 554-562
26. Wood J.E., Schneider H., and Rudd C.E. TcR and TcR-CD28 engagement of protein kinase B (PKB/AKT) and glycogen synthase kinase-3 (GSK-3) operates independently of guanine nucleotide exchange factor VAV1. J. Biol. Chem. 281 (2006) 32385-32394
27. Charvet C., Canonigo A.J., Becart S., Maurer U., Miletic A.V., Swat W., Deckert M., and Altman A. Vav1 promotes T cell cycle progression by linking TCR/CD28 costimulation to FOXO1 and p27kip1 expression. J. Immunol. 177 (2006) 5024-5031
28. Skolnik E.Y., Batzer A., Li N., Lee C.H., Lowenstein E., Mohammadi M., Margolis B., and Schlessinger J. The function of GRB2 in linking the insulin receptor to Ras signaling pathways. Science 260 (1993) 1953-1955
29. Pages F., Ragueneau M., Klasen S., Battifora M., Couez D., Sweet R., Truneh A., Ward S.G., and Olive D. Two distinct intracytoplasmic regions of the T-cell adhesion molecule CD28 participate in phosphatidylinositol 3-kinase association. J. Biol. Chem. 271 (1996) 9403-9409
30. Law C.L., Ewings M.K., Chaudhary P.M., Solow S.A., Yun T.J., Marshall A.J., Hood L., and Clark E.A. GrpL, a Grb2-related adaptor protein, interacts with SLP-76 to regulate nuclear factor of activated T cell activation. J. Exp. Med. 189 (1999) 1243-1253
31. Yankee T.M., Yun T.J., Draves K.E., Ganesh K., Bevan M.J., Murali-Krishna K., and Clark E.A. The Gads (GrpL) adaptor protein regulates T cell homeostasis. J. Immunol. 173 (2004) 1711-1720
32. Shen R., Ouyang Y.B., Qu C.K., Alonso A., Sperzel L., Mustelin T., Kaplan M.H., and Feng G.S. Grap negatively regulates T-cell receptor-elicited lymphocyte proliferation and interleukin-2 induction. Mol. Cell. Biol. 22 (2002) 3230-3236
33. Ramos-Morales F., Romero F., Schweighoffer F., Bismuth G., Camonis J., Tortolero M., and Fischer S. The proline-rich region of Vav binds to Grb2 and Grb3-3. Oncogene 11 (1995) 1665-1669
34. Raab M., Pfister S., and Rudd C.E. CD28 signaling via VAV/SLP-76 adaptors: regulation of cytokine transcription independent of TCR ligation. Immunity 15 (2001) 921-933
35. Michel F., Mangino G., Attal-Bonnefoy G., Tuosto L., Alcover A., Roumier A., Olive D., and Acuto O. CD28 utilizes Vav1 to enhance TCR-proximal signaling and NF-AT activation. J. Immunol. 165 (2000) 3820-3829
36. Michel F., and Acuto O. CD28 costimulation: a source of Vav1 for TCR signaling with the help of SLP-76?. Sci. STKE (2002) PE35
37. Chiu V.K., Bivona T., Hach A., Sajous J.B., Silletti J., Wiener H., Johnson II R.L., Cox A.D., and Philips M.R. Ras signalling on the endoplasmic reticulum and the golgi. Nat. Cell Biol. 4 (2002) 343-350
38. Dustin M.L., Bivona T.G., and Philips M.R. Membranes as messengers in T cell adhesion signaling. Nat. Immunol. 5 (2004) 363-372
39. Marinari B., Costanzo A., Viola A., Michel F., Mangino G., Acuto O., Levrero M., Piccolella E., and Tuosto L. Vav cooperates with CD28 to induce NF-kappaB activation via a pathway involving Rac-1 and mitogen-activated kinase kinase 1. Eur. J. Immunol. 32 (2002) 447-456